Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (49)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by House, A. A.
Right arrow Articles by Hébert, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by House, A. A.
Right arrow Articles by Hébert, P. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2000) 15: 1029-1034
© 2000 European Renal Association-European Dialysis and Transplant Association

Randomized trial of high-flux vs low-flux haemodialysis: effects on homocysteine and lipids

Andrew A. House1,, George A. Wells2, James G. Donnelly3, Steven P. Nadler4 and Paul C. Hébert2,5

1 Division of Nephrology, London Health Sciences Centre, London, Ontario, 2 Clinical Epidemiology Unit, Ottawa Civic Hospital Loeb Research Institute, Ottawa, 3 Division of Biochemistry, Ottawa Hospital, Ottawa, 4 Division of Nephrology, Ottawa Hospital, Ottawa, and 5 Divisions of Respirology and Critical Care, Ottawa Hospital, Ottawa, Ontario, Canada

Background. Uncontrolled studies have found that high-flux haemodialysis favourably modifies homocysteine and lipid profiles. We sought to confirm these findings by carrying out a randomized prospective comparison of high-flux and low-flux polysulphone in chronic, stable dialysis patients.

Methods. Forty-eight patients were randomly assigned to either high or low-flux dialysis for 3 months. Serum levels of homocysteine, lipoprotein (a), and lipids were compared between the treatment groups at monthly intervals.

Results. All patient characteristics and laboratory variables were equally distributed between the groups at baseline. Over the study duration, we observed no differences between high- and low-flux treatment groups for the following outcomes: pre-dialysis homocysteine, lipoprotein (a), total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides (all P>0.05). Geometric mean (interquartile range) homocysteine at baseline was 20.0 (16.8–24.5) and 19.5 (15.3–22.0) µmol/l for the high-and low-flux groups respectively (P=0.80), and levels did not change significantly during the study. We did demonstrate a more pronounced intradialytic effect of high-flux dialysis on homocysteine levels, which fell during dialysis by 42%, compared to 32% with low-flux dialysis (P<0.001).

Conclusions. In this randomized controlled trial, the effects of high-flux and low-flux haemodialysis on homocysteine and lipid profiles were comparable. The greater intradialytic effect of high-flux dialysis on homocysteine did not translate into a significant difference in pre-dialysis levels after 3 months of study.

Keywords: haemodialysis; homocysteine; polysulphone; prospective studies

Correspondence and offprint requests to: Dr Andrew A. House, Division of Nephrology, London Health Sciences Centre, University Campus, PO Box 5339, Stn Ctr CSC, London, Ontario, Canada N6A 5A5.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CJASNHome page
B. L. Urquhart, D. J. Freeman, M. J. Cutler, R. Mainra, J. D. Spence, and A. A. House
Mesna for Treatment of Hyperhomocysteinemia in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Randomized Trial
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1041 - 1047.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. W. Mudge, R. Rogers, P. Hollett, B. Law, K. Reiger, J. J. B. Petrie, L. Price, D. W. Johnson, S. B. Campbell, N. M. Isbel, et al.
Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance
Nephrol. Dial. Transplant., October 1, 2005; 20(10): 2178 - 2185.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. Wanner, U. Bahner, R. Mattern, D. Lang, and J. Passlick-Deetjen
Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients
Nephrol. Dial. Transplant., October 1, 2004; 19(10): 2570 - 2575.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. Boure and R. Vanholder
Which dialyser membrane to choose?
Nephrol. Dial. Transplant., February 1, 2004; 19(2): 293 - 296.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. S. D. Vriese, M. Langlois, D. Bernard, I. Geerolf, L. Stevens, J. R. Boelaert, M. Schurgers, and E. Matthys
Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients
Nephrol. Dial. Transplant., December 1, 2003; 18(12): 2596 - 2600.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. N. Friedman, A. G. Bostom, A. S. Levey, I. H. Rosenberg, J. Selhub, and A. Pierratos
Plasma Total Homocysteine Levels among Patients Undergoing Nocturnal versus Standard Hemodialysis
J. Am. Soc. Nephrol., January 1, 2002; 13(1): 265 - 268.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. N. FRIEDMAN, A. G. BOSTOM, J. SELHUB, A. S. LEVEY, and I. H. ROSENBERG
The Kidney and Homocysteine Metabolism
J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2181 - 2189.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.